Literature DB >> 22751483

RAS, cellular senescence and transformation: the BRCA1 DNA repair pathway at the crossroads.

Zhigang Tu1, Katherine M Aird, Rugang Zhang.   

Abstract

The definition of an oncogene is a gene that actively promotes tumorigenesis. For example, activation of RAS oncogene promotes cell transformation and cancer. Paradoxically, in primary mammalian cells, oncogenic RAS typically triggers cellular senescence, a state of irreversible cell growth arrest. Oncogene-induced senescence is an important tumor suppression mechanism in vivo. Here, we discuss our recent evidence that RAS-induced suppression of DNA repair response via dissociation of BRCA1 from chromatin promotes senescence while predisposing cells to senescence bypass and transformation by allowing for secondary hits. The molecular mechanism we uncovered helps reconcile the tumor-promoting nature of oncogenic RAS with the tumor-suppressing role of oncogene-induced senescence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751483      PMCID: PMC3442802          DOI: 10.4161/sgtp.19884

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  36 in total

1.  BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.

Authors:  Reena Shakya; Latarsha J Reid; Colleen R Reczek; Francesca Cole; Dieter Egli; Chyuan-Sheng Lin; Dirk G deRooij; Steffen Hirsch; Kandasamy Ravi; James B Hicks; Matthias Szabolcs; Maria Jasin; Richard Baer; Thomas Ludwig
Journal:  Science       Date:  2011-10-28       Impact factor: 47.728

Review 2.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

3.  Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence.

Authors:  Zhigang Tu; Katherine M Aird; Benjamin G Bitler; Jasmine P Nicodemus; Neil Beeharry; Bing Xia; Tim J Yen; Rugang Zhang
Journal:  Dev Cell       Date:  2011-12-01       Impact factor: 12.270

4.  A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.

Authors:  Andrea Alimonti; Caterina Nardella; Zhenbang Chen; John G Clohessy; Arkaitz Carracedo; Lloyd C Trotman; Ke Cheng; Shohreh Varmeh; Sara C Kozma; George Thomas; Erika Rosivatz; Rudiger Woscholski; Francesco Cognetti; Howard I Scher; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

5.  Oncogenic Braf induces melanocyte senescence and melanoma in mice.

Authors:  Nathalie Dhomen; Jorge S Reis-Filho; Silvy da Rocha Dias; Robert Hayward; Kay Savage; Veronique Delmas; Lionel Larue; Catrin Pritchard; Richard Marais
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

6.  Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.

Authors:  Raffaella Di Micco; Gabriele Sulli; Miryana Dobreva; Michalis Liontos; Oronza A Botrugno; Gaetano Gargiulo; Roberto dal Zuffo; Valentina Matti; Giovanni d'Ario; Erica Montani; Ciro Mercurio; William C Hahn; Vassilis Gorgoulis; Saverio Minucci; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

7.  Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.

Authors:  Alyssa L Kennedy; Jennifer P Morton; Indrani Manoharan; David M Nelson; Nigel B Jamieson; Jeff S Pawlikowski; Tony McBryan; Brendan Doyle; Colin McKay; Karin A Oien; Greg H Enders; Rugang Zhang; Owen J Sansom; Peter D Adams
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

8.  In vitro and in vivo analysis of B-Myb in basal-like breast cancer.

Authors:  A R Thorner; K A Hoadley; J S Parker; S Winkel; R C Millikan; C M Perou
Journal:  Oncogene       Date:  2008-12-01       Impact factor: 9.867

Review 9.  Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology.

Authors:  V Krizhanovsky; W Xue; L Zender; M Yon; E Hernando; S W Lowe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-01-15

10.  B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells.

Authors:  Maëlle Lorvellec; Stéphanie Dumon; Apolinar Maya-Mendoza; Dean Jackson; Jon Frampton; Paloma García
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

View more
  2 in total

1.  CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.

Authors:  Yu Yan; Athira Narayan; Soonweng Cho; Zhiqiang Cheng; Jun O Liu; Heng Zhu; Guannan Wang; Bryan Wharram; Ala Lisok; Mary Brummet; Harumi Saeki; Tao Huang; Kathleen Gabrielson; Edward Gabrielson; Leslie Cope; Yasmine M Kanaan; Ali Afsari; Tammey Naab; Harris G Yfantis; Stefan Ambs; Martin G Pomper; Saraswati Sukumar; Vanessa F Merino
Journal:  Oncogene       Date:  2021-08-02       Impact factor: 9.867

2.  The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.

Authors:  E Palazzo; M Kellett; C Cataisson; A Gormley; P W Bible; V Pietroni; N Radoja; J Hwang; M Blumenberg; S H Yuspa; M I Morasso
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.